Last checked at 29 Mar 2021 12:30
'Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 26 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,741,312 | 1.35% | 190,549 | 0.15% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
102,935 | 0.08% | 7,066 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,850,347 | 1.43% | 203,715 | 0.16% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 225.3900 USD |
Purchase | 4 | 226.3325 USD |
Purchase | 4 | 224.7100 USD |
Purchase | 9 | 224.7861 USD |
Purchase | 10 | 225.9465 USD |
Purchase | 27 | 226.4700 USD |
Purchase | 84 | 223.9900 USD |
Purchase | 143 | 226.3372 USD |
Purchase | 222 | 226.0497 USD |
Purchase | 243 | 224.4856 USD |
Purchase | 267 | 226.3677 USD |
Purchase | 313 | 226.8889 USD |
Purchase | 362 | 226.6075 USD |
Purchase | 550 | 226.4056 USD |
Purchase | 606 | 227.0831 USD |
Purchase | 881 | 225.8929 USD |
Purchase | 1,541 | 228.0120 USD |
Purchase | 1,780 | 227.2607 USD |
Purchase | 2,562 | 224.7107 USD |
Purchase | 3,865 | 226.1068 USD |
Purchase | 6,200 | 225.9812 USD |
Purchase | 6,694 | 226.2313 USD |
Purchase | 12,715 | 229.0735 USD |
Purchase | 13,536 | 229.3600 USD |
Purchase | 15,052 | 226.0988 USD |
Purchase | 21,893 | 226.0628 USD |
Purchase | 26,094 | 228.3599 USD |
Sale | 2 | 226.2750 USD |
Sale | 4 | 226.7562 USD |
Sale | 6 | 225.8275 USD |
Sale | 18 | 226.7500 USD |
Sale | 36 | 226.8200 USD |
Sale | 41 | 229.2631 USD |
Sale | 46 | 226.6500 USD |
Sale | 48 | 226.3668 USD |
Sale | 48 | 226.6537 USD |
Sale | 54 | 227.1205 USD |
Sale | 60 | 227.7305 USD |
Sale | 62 | 228.3396 USD |
Sale | 84 | 227.4903 USD |
Sale | 93 | 226.5200 USD |
Sale | 96 | 227.1696 USD |
Sale | 100 | 226.6200 USD |
Sale | 100 | 226.4100 USD |
Sale | 114 | 227.5276 USD |
Sale | 114 | 226.8002 USD |
Sale | 128 | 225.7139 USD |
Sale | 140 | 226.0407 USD |
Sale | 150 | 227.4588 USD |
Sale | 197 | 226.4283 USD |
Sale | 200 | 225.9300 USD |
Sale | 267 | 226.3677 USD |
Sale | 363 | 226.4381 USD |
Sale | 518 | 225.5108 USD |
Sale | 608 | 226.0789 USD |
Sale | 663 | 227.0916 USD |
Sale | 743 | 225.7970 USD |
Sale | 890 | 227.2607 USD |
Sale | 1,214 | 224.2330 USD |
Sale | 1,600 | 225.7643 USD |
Sale | 1,675 | 224.9881 USD |
Sale | 2,345 | 225.8638 USD |
Sale | 3,144 | 226.7900 USD |
Sale | 6,945 | 226.2613 USD |
Sale | 7,834 | 225.9458 USD |
Sale | 10,000 | 226.5027 USD |
Sale | 11,597 | 229.3191 USD |
Sale | 12,142 | 229.3600 USD |
Sale | 13,282 | 226.0112 USD |
Sale | 14,481 | 226.0094 USD |
Sale | 22,002 | 228.8467 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 29 Mar 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210329005395/en/
Copyright Business Wire 2021